| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/30/2011 | WO2011076840A2 Aerosol formulation for copd |
| 06/30/2011 | WO2011076812A1 Carboxamide compounds and their use as calpain inhibitors iv |
| 06/30/2011 | WO2011076811A1 Carboxamide compounds and their use as calpain inhibitors |
| 06/30/2011 | WO2011076807A2 Lipids, lipid compositions, and methods of using them |
| 06/30/2011 | WO2011076786A1 Substituted isoquinolinones and quinazolinones |
| 06/30/2011 | WO2011076765A1 Novel antiviral compounds |
| 06/30/2011 | WO2011076747A1 Diaza-spiro[5.5]undecanes as orexin receptor antagonists |
| 06/30/2011 | WO2011076744A1 Disubstituted heteroaryl-fused pyridines |
| 06/30/2011 | WO2011076743A1 Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt |
| 06/30/2011 | WO2011076738A1 Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt |
| 06/30/2011 | WO2011076734A1 Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases |
| 06/30/2011 | WO2011076732A1 Compounds, pharmaceutical composition and methods for use in treating gastrointestinal disorders |
| 06/30/2011 | WO2011076723A1 Amino-heteroaryl derivatives as hcn blockers |
| 06/30/2011 | WO2011076721A1 Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases |
| 06/30/2011 | WO2011076711A2 Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methylpyridine-2-carboxamide |
| 06/30/2011 | WO2011076708A1 New aminotetraline derivatives |
| 06/30/2011 | WO2011076699A1 Bis(difluormethyl)pyrazoles used as fungicides |
| 06/30/2011 | WO2011076687A1 Pyridinone derivatives and pharmaceutical compositions thereof |
| 06/30/2011 | WO2011076678A1 Substituted benzamide derivatives |
| 06/30/2011 | WO2011076621A2 Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
| 06/30/2011 | WO2011076596A1 A combination for the treatment of osteoarthritis |
| 06/30/2011 | WO2011076547A1 Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents |
| 06/30/2011 | WO2011076421A2 Compositions comprising venlafaxine and celecoxib in the treatment of pain |
| 06/30/2011 | WO2011076420A2 Co-crystals of venlafaxine and celecoxib |
| 06/30/2011 | WO2011076419A1 Imidazopyridine derivatives as jak inhibitors |
| 06/30/2011 | WO2011076412A1 Oral form of administration comprising entecavir |
| 06/30/2011 | WO2011076411A1 Orodispersible tablet contained compacted sildenafil base |
| 06/30/2011 | WO2011076401A1 Substantially water-free pharmaceutical compositions containing acetylsalicylic acid |
| 06/30/2011 | WO2011076367A2 Synergistic antiviral composition and use thereof |
| 06/30/2011 | WO2011076363A1 Morphinan-6-one compounds for the treatment or prevention of neurodegenerative diseases |
| 06/30/2011 | WO2011076327A1 Pyrrolo[2,3-d]pyrazin-7-yl pyrimidine compounds |
| 06/30/2011 | WO2011076316A1 Pyrrolopyridinyl-pyrimidin-2-ylamine derivatives |
| 06/30/2011 | WO2011076206A1 Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture |
| 06/30/2011 | WO2011076147A1 Plasma-based micro-rna biomarkers and methods for early detection of colorectal cancer |
| 06/30/2011 | WO2011076145A1 Tissue-based micro-rna methods for diagnosis of different subtypes of lung cancer |
| 06/30/2011 | WO2011076144A1 Compositions and methods for microrna expession profiling in plasma of lung cancer |
| 06/30/2011 | WO2011076143A1 Compositions and methods for microrna expression profiling of lung cancer |
| 06/30/2011 | WO2011076141A1 Diagnostic kits comprising microrna biomarkers and methods for diagnosis of hepatocellular cancer |
| 06/30/2011 | WO2011076086A1 Intermediate compounds of tamiflu, methods of preparation and uses thereof |
| 06/30/2011 | WO2011076048A1 Medical and pharmaceutical use of 2', 2-bis-thiazole non-nucleoside compounds as hepatitis c virus inhibitor |
| 06/30/2011 | WO2011076019A1 Mixed compound medicament of natural medicine component and no donator and use thereof |
| 06/30/2011 | WO2011075958A1 Use of toll-like receptor-3 agonist in the preparation of medicament for promoting wound healing |
| 06/30/2011 | WO2011075957A1 Tetrahydroisoquinoline compounds, preparation methods and uses thereof |
| 06/30/2011 | WO2011075943A1 Agomelatine and pharmaceutical compositions thereof |
| 06/30/2011 | WO2011075935A1 Diphenylethene derivatives and uses thereof |
| 06/30/2011 | WO2011075912A1 Pharmaceutical composition for treating parkinson's disease and preparation method thereof |
| 06/30/2011 | WO2011075801A1 Cubebin, dibenzylbutyrolactone lignan, semi-synthetic and synthetic derivatives thereof, and other lignans and neolignans as vasodilating agents in the therapy of erectile dysfunction |
| 06/30/2011 | WO2011075784A1 Compounds, preparations and uses thereof |
| 06/30/2011 | WO2011075777A1 Neuronal stimulation |
| 06/30/2011 | WO2011075775A1 Carrier composition |
| 06/30/2011 | WO2011075766A1 Antimicrobial compounds |
| 06/30/2011 | WO2011056741A3 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
| 06/30/2011 | WO2011056566A3 Compounds and methods for treatment of cancer |
| 06/30/2011 | WO2011056240A3 Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
| 06/30/2011 | WO2011055383A3 Intranasal delivery to improve the performance of children suffering from dyslexia |
| 06/30/2011 | WO2011055289A3 Carboxy oxazole or thiazole compounds as dgat - 1 inhibitors useful for the treatment of obesity |
| 06/30/2011 | WO2011054990A3 Use of 5' -methylthioadenosine for the inhibition of the epithelial-mesenchymal transition |
| 06/30/2011 | WO2011048148A3 Glycoside derivative and uses thereof |
| 06/30/2011 | WO2011045383A3 2, 6 -diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases |
| 06/30/2011 | WO2011045265A3 Spirocyclic derivatives as histone deacetylase inhibitors |
| 06/30/2011 | WO2011041590A3 1-desoxy-2-methylene-19-nor-vitamin d analogs and their uses |
| 06/30/2011 | WO2011034887A9 A method for treating neuropathic pain |
| 06/30/2011 | WO2011030351A3 Taste - masked pharmaceutical compositions |
| 06/30/2011 | WO2011028938A8 Methods for lowering serum cholesterol in a subject using inhibition of pcsk9 |
| 06/30/2011 | WO2011022467A3 Controlled-release formulations of anabaseine compounds and uses thereof |
| 06/30/2011 | WO2011021818A3 Composition for proliferating epidermal keratinocyte stem cells |
| 06/30/2011 | WO2011020030A3 Methods and compositions to prevent addiction |
| 06/30/2011 | WO2011019986A3 Processes for preparing pemetrexed |
| 06/30/2011 | WO2011019617A3 Vitamin d3 and analogs thereof for treating alopecia |
| 06/30/2011 | WO2011017534A3 Treatment of prostate cancer |
| 06/30/2011 | WO2011017519A3 Inhibitors of methionine aminopeptidases and methods of treating disorders |
| 06/30/2011 | WO2011017350A3 Compounds as lysophosphatidic acid receptor antagonists |
| 06/30/2011 | WO2011016686A3 Prasugrel disulfonate or crystalline forms thereof, method for preparing same, and pharmaceutical composition containing same |
| 06/30/2011 | WO2011014008A3 Novel 3-phenoxy-4-pyrone, 3-phenoxy-4-pyridone, or 4-pyridone derivatives, method for preparing same, and antimicrobial composition containing same as an active ingredient |
| 06/30/2011 | WO2011014003A3 (+)-3-hydroxymorphinan derivatives as neuroprotectants |
| 06/30/2011 | WO2011013992A3 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial |
| 06/30/2011 | WO2011013909A3 Composition containing oligo-hyaluronic acid for promoting the stemness of skin cells and for stimulating differentiation |
| 06/30/2011 | WO2011012855A3 Antibacterial combinations comprising a garlic extract or s -allyl cysteine |
| 06/30/2011 | WO2011012322A3 Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms |
| 06/30/2011 | WO2011011706A3 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents |
| 06/30/2011 | WO2010148065A3 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1 |
| 06/30/2011 | WO2010132999A8 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics |
| 06/30/2011 | WO2010110685A4 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| 06/30/2011 | WO2010092123A8 Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia |
| 06/30/2011 | WO2010070023A3 Pharmaceutical orally deliverable formulations |
| 06/30/2011 | WO2010068292A8 Azaindole derivatives as kinase inhibitors |
| 06/30/2011 | WO2010067010A3 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics |
| 06/30/2011 | WO2009150420A8 Inhibitors of tissue transglutaminase ii as tocolytic agents |
| 06/30/2011 | WO2007113540A8 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle |
| 06/30/2011 | US20110162107 Plants having improved growth characteristics and methods for making the same |
| 06/30/2011 | US20110160642 Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases |
| 06/30/2011 | US20110160309 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
| 06/30/2011 | US20110160308 Use of Monoamine Oxidase Inhibitors to Treat Outer Retina Disorders |
| 06/30/2011 | US20110160307 Compositions and Methods for Treating Hemorrhagic Conditions |
| 06/30/2011 | US20110160306 Use of alkanedicarboxylic acids and retinoids for treatment of rosacea and other inflammatory skin diseases |
| 06/30/2011 | US20110160305 Oral Delivery of Therapeutic Doses of Glutathione |
| 06/30/2011 | US20110160304 Inhibitors of Yeast Filamentous Growth and Method of Their Manufacture |
| 06/30/2011 | US20110160303 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
| 06/30/2011 | US20110160302 Device and methods for treatment and prevention of tendon injuries |
| 06/30/2011 | US20110160301 Ascorbate, vitamin k3 and hydroxytolans in the treatment of cancer |